BPC-157, short for Body Protective Compound 157, is a synthetic peptide derived from a protein found in human gastric juice
The 96372 CPT code description refers to the administration of a therapeutic, prophylactic, or diagnostic injection, given intramuscularly (IM) or subcutaneously (SQ)
BPC-157 is usually twice daily, smaller volume, and best near injury site
not primarily appetite-driven (OUP Academic) Expected weight loss (this is where many people get misled) In major obesity trials: Semaglutide 2.4 mg weekly: ~14.9% mean weight loss at 68 weeks (STEP-1) (PubMed) Tirzepatide: ~15.0% to ~20.9% mean weight loss at 72 weeks , dose-dependent (SURMOUNT-1) (PubMed) AOD-9604s best-known human signal is kilograms, not double-digit percentages , and later studies did not sustain a strong obesity-drug profile
A vet whos never used it and read a warning label isnt the same as one who has used it in dozens of cases and knows what to watch for